Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Market Update

Julia Lee
March 20, 2017

Market Update

Julia Lee
March 17, 2017

Market Update

Julia Lee
March 16, 2017

Market Update 15 March 2017

Julia Lee
March 15, 2017

How to review your portfolio

Bell Direct
March 14, 2017

Market Update

Julia Lee
March 13, 2017

Market Update

Julia Lee
March 10, 2017

Market Update 9 Mar

Julia Lee
March 9, 2017

Market Update

Julia Lee
March 8, 2017

Market Update

Julia Lee
March 6, 2017

Market Update 3 March

Julia Lee
March 3, 2017